Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05242861

Retrospective Study of Brachytherapy

Brachytherapy for gynecological cancers will be studied retrospectively.

Recruiting

Interested in participating?

Request Info

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18 - 80 female
  • Underwent brachytherapy
  • With gynecological cancer

Exclusion criteria

  • Refusal to enter this trial

Treatment and study plan

Brachytherapy

Radiation

Applicator, dose, schedule, technology, image, 3D print, efficacy, toxicity of brachytherapy

Primary outcomes

  1. Overall survival rate

    Time frame: 5-year

    the percentage of participants in the group who survives

Secondary outcomes

  1. Progression-free survival rate

    Time frame: 5-year

    the percentage of participants in the group whose disease is likely to remain stable

  2. Side effects

    Time frame: 5-year

    side effects associated with treatment

Sponsors and collaborators

Lead sponsor

Zhejiang Cancer Hospital

Other

Registry information

Official study title

A Retrospective Study of Brachytherapy in Gynecological Cancers

Acronym: RetroBT

Important dates

Study start
2022
Primary completion
2024
Study completion
2027
First posted
Feb 16, 2022
Registry last updated
Feb 16, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.